Delivery Order SPE2DB20D3103-SPE2DB22FP7N6
Award Date 9/2/22
Potential Completion Date 9/6/22
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,564.87, is for the delivery of Zortress 0.75 mg tablets. It is a firm-fixed price delivery order contract with a completion date of March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $3,956.65, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through November 2026. The contract is for the supply of pharmaceutical products, including the drug Zortress in 0.75 mg tablet form. As the award is not designated with a set-aside, it appears to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product, with a ceiling value of $2,340.05 and a period of performance through July 2, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.83 firm fixed-price delivery order is for the supply of Zortress 0.25 mg tablet medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of pharmaceutical products, specifically Zortress 0.75 mg tablets, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $83,882.03 firm-fixed-price contract was issued by the Defense Logistics Agency (DLA) on January 25, 2022, with a completion date of January 26, 2022. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Zortress (everolimus) 0.5 mg tablets. The $5,558.16 firm fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Zortress 0.5 mg tablets in unit dose packaging (60 count), valued at $3,677.57. This is a firm fixed price delivery order with no set-aside designation, demonstrating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of ZORTRESS 0.5 MG TABLET UD 60S, a prescription pharmaceutical product. The contract has a total ceiling value of $7,437.20 and a completion date of September 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical and medical products to the federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Zortress (everolimus) 0.25 mg tablets. The award is a delivery order with a firm fixed price of $3,385.45 and an ultimate completion date of August 1, 2024. The contract does not have a set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA, AmerisourceBergen is a key supplier of a wide range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zortress 0.5 mg tablets in unit dose packaging (60-count) under a firm fixed-price contract valued at $9,306.29, with an ultimate completion date of August 15, 2025. This non-set-aside award represents a continuation of pharmaceutical supply support through AmerisourceBergen's existing relationship with DLA. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This...